Research output per year
Research output per year
Personal profile
Research interests
Mechanisms underlying cytokine-induced memory-like natural killer cell differentiation and maintenance.
Fingerprint
Dive into the research topics where Melissa Berrien-Elliott is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Allogeneic natural killer cell therapy
Berrien-Elliott, M. M., Jacobs, M. T. & Fehniger, T. A., Feb 23 2023, In: Blood. 141, 8, p. 856-868 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cells
Cubitt, C. C., McClain, E., Becker-Hapak, M., Foltz, J. A., Wong, P., Wagner, J. A., Neal, C. C., Marin, N. D., Marsala, L., Foster, M., Schappe, T., Soon-Shiong, P., Lee, J., Berrien-Elliott, M. M. & Fehniger, T. A., Mar 17 2022, In: Molecular Therapy - Oncolytics. 24, p. 585-596 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Donor memory-like NK cells persist and induce remissions in pediatric patients with relapsed AML after transplant
Bednarski, J. J., Zimmerman, C., Berrien-Elliott, M. M., Foltz, J. A., Becker-Hapak, M., Neal, C. C., Foster, M., Schappe, T., McClain, E., Pence, P. P., Desai, S., Kersting-Schadek, S., Wong, P., Russler-Germain, D. A., Fisk, B., Lie, W. R., Eisele, J., Hyde, S., Bhatt, S., Griffith, O. L., & 4 others, Mar 17 2022, In: Blood. 139, 11, p. 1670-1683 14 p.Research output: Contribution to journal › Article › peer-review
21 Scopus citations -
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia
Berrien-Elliott, M. M., Foltz, J. A., Russler-Germain, D. A., Neal, C. C., Tran, J., Gang, M., Wong, P., Fisk, B., Cubitt, C. C., Marin, N. D., Zhou, A. Y., Jacobs, M. T., Foster, M., Schappe, T., McClain, E., Kersting-Schadek, S., Desai, S., Pence, P., Becker-Hapak, M., Eisele, J., & 20 others, Feb 23 2022, In: Science translational medicine. 14, 633, abm1375.Research output: Contribution to journal › Article › peer-review
14 Scopus citations -
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphoma
Ward, J. P., Berrien-Elliott, M. M., Gomez, F., Luo, J., Becker-Hapak, M., Cashen, A. F., Wagner-Johnston, N. D., Maddocks, K., Mosior, M., Foster, M., Krysiak, K., Schmidt, A., Skidmore, Z. L., Desai, S., Watkins, M. P., Fischer, A., Griffith, M., Griffith, O. L., Fehniger, T. A. & Bartlett, N. L., Mar 31 2022, In: Blood. 139, 13, p. 1999-2010 12 p.Research output: Contribution to journal › Article › peer-review
6 Scopus citations